Chun-Wei Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chun-Wei Pan has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Bilal Ibrahim
Medical Graduate, Aga Khan University Hospital, Karachi 74800, Pakistan
3 shared publications - Pojsakorn Danpanichkul
Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA
3 shared publications Sania Saleem
3 shared publications- Ayusha Poudel
Intensive Care Unit, Nepal Korea Friendship Municipality Hospital, Kathmandu, NPL
2 shared publications - Bashar Attar
Gastroenterology and Hepatology, Rush University Medical Center, Chicago, USA
2 shared publications - Ikechukwu Achebe
Cook County Hospital, Chicago, IL, USA
2 shared publications
Latest Publications
- 7 November 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (12) , 2766-2778
Alarming rise in alcohol‐associated liver disease hospitalization in young adults
Background: Alcohol‐associated liver disease (ALD) is increasingly affecting young adults, but comprehensive analyses of hospitalization patterns in this demographic remain limited. We aimed to evaluate trends in hospitalization rates, disease severity, and healthcare costs for ALD among adults aged 20–49 years compared with older adults. Methods: We conducted a retrospective analysis using the National Inpatient Sample (2016–2022) to evaluate ALD‐related hospitalizations in adults ≥20 years. Using ICD‐10 codes, we identified hospitalization of ALD, alcohol‐associated cirrhosis and alcohol‐associated hepatitis, analyzing hospitalization rates, decompensation rates, and inflation‐adjusted costs. Temporal trends were assessed using joinpoint regression analysis with results expressed as mean annual percentage change and Cochrane–Armitage test. Results: Among 1,159,959 hospitalizations in young adults with ALD, rates increased more steeply compared to older adults (annual increase: 4.48% vs. 1.78%), rising from 106.5 to 144.7 per 100,000 persons versus 269.5 to 295.0 per 100,000 persons, respectively. By 2020, alcohol‐associated hepatitis hospitalization rates in young adults surpassed older adults (65.6 vs. 61.3 per 100,000). The 30–39 age group represented the largest increase (31% to 37.5%) among young adults. Decompensated alcohol‐associated cirrhosis increased across all age groups, most prominently in ages 20–29 (31.3% to 36.4%). National costs doubled from $1.69 billion to $3.45 billion. Conclusion: Young adults demonstrated accelerated increases in ALD‐related hospitalizations and disease severity compared to older adults, with a particularly pronounced trend during the pandemic period. These findings suggest a need for age‐specific preventive and therapeutic interventions.
- 7 November 2025
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 49 (12) , 2766-2778
Alarming rise in alcohol‐associated liver disease hospitalization in young adults
Background: Alcohol‐associated liver disease (ALD) is increasingly affecting young adults, but comprehensive analyses of hospitalization patterns in this demographic remain limited. We aimed to evaluate trends in hospitalization rates, disease severity, and healthcare costs for ALD among adults aged 20–49 years compared with older adults. Methods: We conducted a retrospective analysis using the National Inpatient Sample (2016–2022) to evaluate ALD‐related hospitalizations in adults ≥20 years. Using ICD‐10 codes, we identified hospitalization of ALD, alcohol‐associated cirrhosis and alcohol‐associated hepatitis, analyzing hospitalization rates, decompensation rates, and inflation‐adjusted costs. Temporal trends were assessed using joinpoint regression analysis with results expressed as mean annual percentage change and Cochrane–Armitage test. Results: Among 1,159,959 hospitalizations in young adults with ALD, rates increased more steeply compared to older adults (annual increase: 4.48% vs. 1.78%), rising from 106.5 to 144.7 per 100,000 persons versus 269.5 to 295.0 per 100,000 persons, respectively. By 2020, alcohol‐associated hepatitis hospitalization rates in young adults surpassed older adults (65.6 vs. 61.3 per 100,000). The 30–39 age group represented the largest increase (31% to 37.5%) among young adults. Decompensated alcohol‐associated cirrhosis increased across all age groups, most prominently in ages 20–29 (31.3% to 36.4%). National costs doubled from $1.69 billion to $3.45 billion. Conclusion: Young adults demonstrated accelerated increases in ALD‐related hospitalizations and disease severity compared to older adults, with a particularly pronounced trend during the pandemic period. These findings suggest a need for age‐specific preventive and therapeutic interventions.
- 23 June 2025
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 60 (8) , 758-765
Trends in Urban-rural Disparities in Hepatocellular Carcinoma Mortality in the United States From 1999 to 2020
Objective: Hepatocellular carcinoma (HCC) is a growing public health concern in the United States. While socioeconomic factors have been linked to HCC outcomes, the impact of urban-rural residence remains understudied. This analysis examines trends in HCC mortality between urban and rural areas from 1999 to 2020. Materials and Methods: Using the “Centers for Disease Control and Prevention Wide Ranging Online Data for Epidemiologic Research” database, we analyzed age-adjusted HCC mortality rates in urban and rural counties. Joinpoint regression was used to calculate annual percentage change and average annual percentage change (AAPC) in mortality rates. We examined trends by demographics and geographic regions. Results: Overall HCC mortality increased from 1999 to 2020 (AAPC: 1.24%). Rural areas experienced a more rapid rise (AAPC: 1.97%) in HCC mortality compared with urban areas (AAPC: 1.11%), and in 2020 HCC mortality in rural areas surpassed that in urban areas. Significant disparities in HCC mortality were also observed by other sociodemographic factors, with the highest HCC mortality among men, older adults, and ethnic minority populations in rural regions. Conclusion: Significant disparities in HCC mortality were observed by urban-rural geography in the United States, which seems to be exacerbated by underlying sociodemographic factors. Better understanding of potential modifiable drivers of these disparities will help guide interventions to improve long-term patient outcomes.
- 23 June 2025
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 60 (8) , 758-765
Trends in Urban-rural Disparities in Hepatocellular Carcinoma Mortality in the United States From 1999 to 2020
Objective: Hepatocellular carcinoma (HCC) is a growing public health concern in the United States. While socioeconomic factors have been linked to HCC outcomes, the impact of urban-rural residence remains understudied. This analysis examines trends in HCC mortality between urban and rural areas from 1999 to 2020. Materials and Methods: Using the “Centers for Disease Control and Prevention Wide Ranging Online Data for Epidemiologic Research” database, we analyzed age-adjusted HCC mortality rates in urban and rural counties. Joinpoint regression was used to calculate annual percentage change and average annual percentage change (AAPC) in mortality rates. We examined trends by demographics and geographic regions. Results: Overall HCC mortality increased from 1999 to 2020 (AAPC: 1.24%). Rural areas experienced a more rapid rise (AAPC: 1.97%) in HCC mortality compared with urban areas (AAPC: 1.11%), and in 2020 HCC mortality in rural areas surpassed that in urban areas. Significant disparities in HCC mortality were also observed by other sociodemographic factors, with the highest HCC mortality among men, older adults, and ethnic minority populations in rural regions. Conclusion: Significant disparities in HCC mortality were observed by urban-rural geography in the United States, which seems to be exacerbated by underlying sociodemographic factors. Better understanding of potential modifiable drivers of these disparities will help guide interventions to improve long-term patient outcomes.
- 5 January 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (6) , 959-970
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Objective: Primary liver cancer (PLC) is projected to be the third leading cause of cancer mortality in the United States in 2040. We examine the burden of PLC in the United States, stratified by sex, state and aetiological risk factors.Methods: Data on PLC prevalence, incidence, death and disability–adjusted life years (DALYs) were extracted from the Global Burden of Disease Study 2021. Changes in these parameters were calculated using the Joinpoint regression model.Results: There were 47,970 cases, 31,450 incident cases, 24,770 deaths and 576,920 DALYs from PLC in the United States. The highest prevalence (16,980), incidence (12,040), death (9840) and DALYs (213,410) from PLC were due to chronic hepatitis C virus infection. From 2000 to 2021, PLC incidences increased by 141%, and PLC deaths increased by 136%. Age–standardised incidence rates (ASIRs) and death rates (ASDRs) per 100,000 population for PLC increased, primarily driven by alcohol–related liver disease (ALD) (ASIR: annual percent change [APC]: +2.40%; ASDR: APC: +2.22%) and metabolic dysfunction–associated steatotic liver disease (MASLD) (ASIR: APC: +2.32%; ASDR: APC: +2.04%).Conclusion: The burden of PLC in the United States has risen in the past two decades, driven mainly by ALD and followed by MASLD. These findings offer policymakers an accurate assessment of the PLC burden and emphasise the need for targeted risk factor mitigation, especially regarding alcohol related policy.
- 5 January 2025
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (6) , 959-970
Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Objective: Primary liver cancer (PLC) is projected to be the third leading cause of cancer mortality in the United States in 2040. We examine the burden of PLC in the United States, stratified by sex, state and aetiological risk factors.Methods: Data on PLC prevalence, incidence, death and disability–adjusted life years (DALYs) were extracted from the Global Burden of Disease Study 2021. Changes in these parameters were calculated using the Joinpoint regression model.Results: There were 47,970 cases, 31,450 incident cases, 24,770 deaths and 576,920 DALYs from PLC in the United States. The highest prevalence (16,980), incidence (12,040), death (9840) and DALYs (213,410) from PLC were due to chronic hepatitis C virus infection. From 2000 to 2021, PLC incidences increased by 141%, and PLC deaths increased by 136%. Age–standardised incidence rates (ASIRs) and death rates (ASDRs) per 100,000 population for PLC increased, primarily driven by alcohol–related liver disease (ALD) (ASIR: annual percent change [APC]: +2.40%; ASDR: APC: +2.22%) and metabolic dysfunction–associated steatotic liver disease (MASLD) (ASIR: APC: +2.32%; ASDR: APC: +2.04%).Conclusion: The burden of PLC in the United States has risen in the past two decades, driven mainly by ALD and followed by MASLD. These findings offer policymakers an accurate assessment of the PLC burden and emphasise the need for targeted risk factor mitigation, especially regarding alcohol related policy.
- Open Access
- 26 November 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (5) , 1135-1139
Seasonal Patterns in Eosinophilic Esophagitis-Related Emergency Department Visits: A National Database Analysis
INTRODUCTION: This study investigates seasonal variations in eosinophilic esophagitis (EoE)-related emergency department visits among adults. METHODS: We analyzed the National Emergency Department Sample (2016–2021), identifying adult patients with EoE using ICD-10 codes. Generalized additive models assessed seasonal patterns. RESULTS: Among 18,791 EoE-related emergency department visits, a significant seasonal variation was observed, peaking in summer and nadiring in winter. This pattern was consistent across all US regions. CONCLUSION: Seasonal dietary habits and social behaviors likely contribute to EoE exacerbations. Healthcare providers should emphasize management strategies during high-risk periods, particularly summer months and weekends.
- 26 November 2024
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 120 (5) , 1135-1139
Open AccessSeasonal Patterns in Eosinophilic Esophagitis-Related Emergency Department Visits: A National Database Analysis
INTRODUCTION: This study investigates seasonal variations in eosinophilic esophagitis (EoE)-related emergency department visits among adults. METHODS: We analyzed the National Emergency Department Sample (2016–2021), identifying adult patients with EoE using ICD-10 codes. Generalized additive models assessed seasonal patterns. RESULTS: Among 18,791 EoE-related emergency department visits, a significant seasonal variation was observed, peaking in summer and nadiring in winter. This pattern was consistent across all US regions. CONCLUSION: Seasonal dietary habits and social behaviors likely contribute to EoE exacerbations. Healthcare providers should emphasize management strategies during high-risk periods, particularly summer months and weekends.
- 24 July 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (11) , 2340-2350
Esophageal cancer mortality disparities between Black and White adults in the United States, 1999–2020: insights from CDC‐WONDER
Background and Aim: Esophageal cancer significantly contributes to US cancer mortality, with notable racial disparities. This study aims to provide updated esophageal cancer mortality trends among Black and White adults from 1999 to 2020.Methods: CDC‐WONDER was used to identify Black and White adults in the United States from 1999 to 2020. We calculated age‐standardized mortality rates, absolute rate differences, and rate ratios to compare the mortality differences between these populations.Results: From 1999 to 2020 in the United States, there were 303 267 esophageal cancer deaths, with significant racial disparities. The age‐adjusted mortality rate for Black adults fell from 6.52 to 2.62 per 100 000, while for White adults, it declined from 4.19 to 3.97 per 100 000, narrowing the racial mortality gap. Gender‐wise, the study showed a decrease in the mortality rate from 3.31 to 2.29 per 100 000 in Black women, but an increase from 1.52 to 1.99 per 100 000 in White women. Among young men, the rate dropped in Black men from 12.82 to 6.26 per 100 000 but rose in White men from 9.90 to 10.57 per 100 000. Regionally, Black adults in the Midwest and South initially had higher mortality rates than Whites, but this gap reduced over time. By 2020, Black men had lower mortality rates across all regions.Conclusions: Over the last two decades, age‐adjusted esophageal cancer mortality decreased in Black adults but stabilized in White adults, reflecting distinct cancer trends and risk factors. The study highlights the importance of tailored public health strategies for healthcare access and risk factor management.
- 24 July 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (11) , 2340-2350
Esophageal cancer mortality disparities between Black and White adults in the United States, 1999–2020: insights from CDC‐WONDER
Background and Aim: Esophageal cancer significantly contributes to US cancer mortality, with notable racial disparities. This study aims to provide updated esophageal cancer mortality trends among Black and White adults from 1999 to 2020.Methods: CDC‐WONDER was used to identify Black and White adults in the United States from 1999 to 2020. We calculated age‐standardized mortality rates, absolute rate differences, and rate ratios to compare the mortality differences between these populations.Results: From 1999 to 2020 in the United States, there were 303 267 esophageal cancer deaths, with significant racial disparities. The age‐adjusted mortality rate for Black adults fell from 6.52 to 2.62 per 100 000, while for White adults, it declined from 4.19 to 3.97 per 100 000, narrowing the racial mortality gap. Gender‐wise, the study showed a decrease in the mortality rate from 3.31 to 2.29 per 100 000 in Black women, but an increase from 1.52 to 1.99 per 100 000 in White women. Among young men, the rate dropped in Black men from 12.82 to 6.26 per 100 000 but rose in White men from 9.90 to 10.57 per 100 000. Regionally, Black adults in the Midwest and South initially had higher mortality rates than Whites, but this gap reduced over time. By 2020, Black men had lower mortality rates across all regions.Conclusions: Over the last two decades, age‐adjusted esophageal cancer mortality decreased in Black adults but stabilized in White adults, reflecting distinct cancer trends and risk factors. The study highlights the importance of tailored public health strategies for healthcare access and risk factor management.
- Open Access
- 4 July 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (13) , e7457
Racial and ethnic disparities in gallbladder cancer: A two‐decade analysis of incidence and mortality rates in the US
Background: Gallbladder cancer (GBC) is an aggressive malignancy that is usually diagnosed at a late stage. Prior data showed increasing incidence of GBC in the US. However, little is known about race/ethnic‐specific incidence and mortality trends of GBC per stage at diagnosis. Therefore, we aimed to conduct a time‐trend analysis of GBC incidence and mortality rates categorized by race/ethnicity and stage‐at‐diagnosis.Methods: Age‐adjusted GBC incidence and mortality rates were calculated using SEER*Stat software from the United States Cancer Statistics database (covers ~98% of US population between 2001 and 2020) and NCHS (covers ~100% of the US population between 2000 and 2020) databases, respectively. Race/Ethnic groups were Non‐Hispanic‐White (NHW), Non‐Hispanic‐Black (NHB), Hispanic, Non‐Hispanic‐Asian/Pacific‐Islander (NHAPI), and Non‐Hispanic‐American‐Indian/Alaska‐Native (NHAIAN). Stage‐at‐diagnoses were all stages, early, regional, and distant stages. Joinpoint regression was used to generate time‐trends [annual percentage change (APC) and average APC (AAPC)] with parametric estimations and a two‐sided t‐test (p‐value cut‐off 0.05).Results: 76,873 patients were diagnosed with GBC with decreasing incidence rates in all races/ethnicities except NHB who experienced an increasing trend between 2001 and 2014 (APC = 2.08, p < 0.01) and plateauing afterward (APC = −1.21, p = 0.31); (AAPC = 1.03, p = 0.03). Among early‐stage tumors (9927 patients), incidence rates were decreasing only in Hispanic (AAPC = −4.24, p = 0.006) while stable in other races/ethnicities (NHW: AAPC = −2.61, p = 0.39; NHB: AAPC = −1.73, p = 0.36). For regional‐stage tumors (29,690 patients), GBC incidence rates were decreasing only in NHW (AAPC = −1.61, p < 0.001) while stable in other races/ethnicities (NHB: AAPC = 0.73, p = 0.34; Hispanic: AAPC = −1.58, p = 0.24; NHAPI: AAPC = −1.22, p = 0.07). For distant‐stage tumors (31,735 patients), incidence rates were increasing in NHB (AAPC = 2.72, p < 0.001), decreasing in Hispanic (AAPC = −0.64, p = 0.04), and stable in NHW (AAPC = 0.07, p = 0.84) and NHAPI (AAPC = 0.79, p = 0.13). There were 43,411 deaths attributed to GBC with decreasing mortality rates in all races/ethnicities except NHB who experienced a stable trend (AAPC = 0.25, p = 0.25).Conclusion: Nationwide data over the last two decades show that NHB patients experienced increasing GBC incidence between 2001 and 2014 followed by stabilization of the rates. This increase was driven by late‐stage tumors and occurred in the first decade. NHB also experienced non‐improving GBC mortality, compared to other race and ethnic groups who had decreasing mortality. This can be due to lack of timely‐access to healthcare leading to delayed diagnosis and worse outcomes. Future studies are warranted to investigate contributions to the revealed racial and ethnic disparities, especially in NHB, to improve early detection.
- 4 July 2024
- Published by Wiley in Cancer Medicine
- Vol. 13 (13) , e7457
Open AccessRacial and ethnic disparities in gallbladder cancer: A two‐decade analysis of incidence and mortality rates in the US
Background: Gallbladder cancer (GBC) is an aggressive malignancy that is usually diagnosed at a late stage. Prior data showed increasing incidence of GBC in the US. However, little is known about race/ethnic‐specific incidence and mortality trends of GBC per stage at diagnosis. Therefore, we aimed to conduct a time‐trend analysis of GBC incidence and mortality rates categorized by race/ethnicity and stage‐at‐diagnosis.Methods: Age‐adjusted GBC incidence and mortality rates were calculated using SEER*Stat software from the United States Cancer Statistics database (covers ~98% of US population between 2001 and 2020) and NCHS (covers ~100% of the US population between 2000 and 2020) databases, respectively. Race/Ethnic groups were Non‐Hispanic‐White (NHW), Non‐Hispanic‐Black (NHB), Hispanic, Non‐Hispanic‐Asian/Pacific‐Islander (NHAPI), and Non‐Hispanic‐American‐Indian/Alaska‐Native (NHAIAN). Stage‐at‐diagnoses were all stages, early, regional, and distant stages. Joinpoint regression was used to generate time‐trends [annual percentage change (APC) and average APC (AAPC)] with parametric estimations and a two‐sided t‐test (p‐value cut‐off 0.05).Results: 76,873 patients were diagnosed with GBC with decreasing incidence rates in all races/ethnicities except NHB who experienced an increasing trend between 2001 and 2014 (APC = 2.08, p < 0.01) and plateauing afterward (APC = −1.21, p = 0.31); (AAPC = 1.03, p = 0.03). Among early‐stage tumors (9927 patients), incidence rates were decreasing only in Hispanic (AAPC = −4.24, p = 0.006) while stable in other races/ethnicities (NHW: AAPC = −2.61, p = 0.39; NHB: AAPC = −1.73, p = 0.36). For regional‐stage tumors (29,690 patients), GBC incidence rates were decreasing only in NHW (AAPC = −1.61, p < 0.001) while stable in other races/ethnicities (NHB: AAPC = 0.73, p = 0.34; Hispanic: AAPC = −1.58, p = 0.24; NHAPI: AAPC = −1.22, p = 0.07). For distant‐stage tumors (31,735 patients), incidence rates were increasing in NHB (AAPC = 2.72, p < 0.001), decreasing in Hispanic (AAPC = −0.64, p = 0.04), and stable in NHW (AAPC = 0.07, p = 0.84) and NHAPI (AAPC = 0.79, p = 0.13). There were 43,411 deaths attributed to GBC with decreasing mortality rates in all races/ethnicities except NHB who experienced a stable trend (AAPC = 0.25, p = 0.25).Conclusion: Nationwide data over the last two decades show that NHB patients experienced increasing GBC incidence between 2001 and 2014 followed by stabilization of the rates. This increase was driven by late‐stage tumors and occurred in the first decade. NHB also experienced non‐improving GBC mortality, compared to other race and ethnic groups who had decreasing mortality. This can be due to lack of timely‐access to healthcare leading to delayed diagnosis and worse outcomes. Future studies are warranted to investigate contributions to the revealed racial and ethnic disparities, especially in NHB, to improve early detection.
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Sa1572 IMPACT OF PROTEIN ENERGY MALNUTRITION ON INFECTIOUS OUTCOMES OF HOSPITALIZATIONS FOR CIRRHOSIS: A NATIONWIDE RETROSPECTIVE COHORT STUDY
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Sa1572 IMPACT OF PROTEIN ENERGY MALNUTRITION ON INFECTIOUS OUTCOMES OF HOSPITALIZATIONS FOR CIRRHOSIS: A NATIONWIDE RETROSPECTIVE COHORT STUDY
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Tu1005 SURVIVAL DIFFERENCE OF COLORECTAL ADENOCARCINOMA AMONG ETHNIC MINORITIES: SEER DATABASE STUDY
- 6 July 2023
- Published by Elsevier in Gastroenterology
- Vol. 164 (6)
Tu1005 SURVIVAL DIFFERENCE OF COLORECTAL ADENOCARCINOMA AMONG ETHNIC MINORITIES: SEER DATABASE STUDY